PDB Short entry for 2ONF HEADER OXIDOREDUCTASE 23-JAN-07 2ONF TITLE CRYSTAL STRUCTURE OF A PUTATIVE OSMOTICALLY INDUCIBLE PROTEIN C TITLE 2 (TA0195) FROM THERMOPLASMA ACIDOPHILUM AT 1.70 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: HYPOTHETICAL PROTEIN TA0195; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: THERMOPLASMA ACIDOPHILUM; SOURCE 3 ORGANISM_TAXID: 2303; SOURCE 4 STRAIN: AMRC-C165, DSM1728, IFO15155, JCM9062; SOURCE 5 ATCC: 25905; SOURCE 6 GENE: NP_393673.1, TA0195; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, KEYWDS 2 PROTEIN STRUCTURE INITIATIVE, PSI-2, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 7 25-JAN-23 2ONF 1 REMARK SEQADV LINK REVDAT 6 25-OCT-17 2ONF 1 REMARK REVDAT 5 18-OCT-17 2ONF 1 REMARK REVDAT 4 13-JUL-11 2ONF 1 VERSN REVDAT 3 23-MAR-11 2ONF 1 HEADER TITLE KEYWDS REVDAT 2 24-FEB-09 2ONF 1 VERSN REVDAT 1 06-FEB-07 2ONF 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (NP_393673.1) FROM JRNL TITL 2 THERMOPLASMA ACIDOPHILUM AT 1.70 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.93 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 33399 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.164 REMARK 3 R VALUE (WORKING SET) : 0.162 REMARK 3 FREE R VALUE : 0.201 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1697 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2292 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.91 REMARK 3 BIN R VALUE (WORKING SET) : 0.2400 REMARK 3 BIN FREE R VALUE SET COUNT : 121 REMARK 3 BIN FREE R VALUE : 0.2890 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2260 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 306 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 28.91 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.39000 REMARK 3 B22 (A**2) : -0.42000 REMARK 3 B33 (A**2) : 2.09000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.96000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.102 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.103 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.078 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.534 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.970 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.952 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2507 ; 0.017 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1765 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3415 ; 1.696 ; 1.984 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4307 ; 0.972 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 315 ; 5.879 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 125 ;37.429 ;24.080 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 440 ;13.784 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;20.214 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 359 ; 0.103 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2767 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 511 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 413 ; 0.214 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1836 ; 0.206 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1137 ; 0.181 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1299 ; 0.085 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 244 ; 0.157 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 5 ; 0.160 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 25 ; 0.253 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 11 ; 0.162 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1621 ; 2.319 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 579 ; 0.572 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2391 ; 2.886 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1154 ; 5.092 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1005 ; 6.907 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 0 A 139 REMARK 3 RESIDUE RANGE : B 0 B 139 REMARK 3 ORIGIN FOR THE GROUP (A): 24.8092 12.0500 10.5566 REMARK 3 T TENSOR REMARK 3 T11: -0.0425 T22: -0.0208 REMARK 3 T33: -0.0570 T12: 0.0134 REMARK 3 T13: -0.0007 T23: -0.0105 REMARK 3 L TENSOR REMARK 3 L11: 1.0474 L22: 0.9590 REMARK 3 L33: 0.3031 L12: 0.6326 REMARK 3 L13: -0.1780 L23: -0.1927 REMARK 3 S TENSOR REMARK 3 S11: -0.0170 S12: -0.1015 S13: 0.0270 REMARK 3 S21: 0.0081 S22: 0.0109 S23: 0.0178 REMARK 3 S31: 0.0103 S32: 0.0121 S33: 0.0061 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN RIDING POSITIONS. REMARK 3 2. ATOM RECORD CONTAINS RESIDUAL B FACTORS ONLY. REMARK 3 3. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY REMARK 3 OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 REMARK 3 TO ACCOUNT FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL REMARK 3 S-MET INCORPORATION. REMARK 3 4. ONE COENZYME A (COA) MONOMER WAS MODELED IN THE REMARK 3 ACTIVE SITE BASED ON THE PRESENCE OF CLEAR AND REMARK 3 CONCLUSIVE ELECTRON DENSITY. REMARK 4 REMARK 4 2ONF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-JAN-07. REMARK 100 THE DEPOSITION ID IS D_1000041351. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-DEC-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837, 0.97910 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 (HORIZONTAL FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33417 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 27.929 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.03200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.3400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.31500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NANODROP, 30.0% PEG-6000, 0.1M MES PH REMARK 280 6.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.27500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 300 SIZE EXCLUSION CHROMATOGRAPHY WITH STATIC LIGHT REMARK 300 SCATTERING SUPPORTS THE ASSIGNMENT OF A DIMER AS A REMARK 300 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8390 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11930 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 94 CD CE NZ REMARK 470 ARG B 92 CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 15 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG B 127 NE - CZ - NH2 ANGL. DEV. = -3.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 11 -70.83 -81.64 REMARK 500 ASP A 13 -130.80 48.85 REMARK 500 ARG A 14 48.66 -109.33 REMARK 500 LYS A 86 165.50 73.74 REMARK 500 ASN A 128 -11.58 75.14 REMARK 500 ASP B 13 -124.04 48.15 REMARK 500 LYS B 86 168.91 69.66 REMARK 500 ASN B 128 -9.49 72.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE COA B 140 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 140 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 141 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 141 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 142 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 370499 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE REMARK 999 LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 2ONF A 1 139 UNP Q9HLN2 Q9HLN2_THEAC 1 139 DBREF 2ONF B 1 139 UNP Q9HLN2 Q9HLN2_THEAC 1 139 SEQADV 2ONF GLY A 0 UNP Q9HLN2 EXPRESSION TAG SEQADV 2ONF MSE A 1 UNP Q9HLN2 MET 1 MODIFIED RESIDUE SEQADV 2ONF MSE A 65 UNP Q9HLN2 MET 65 MODIFIED RESIDUE SEQADV 2ONF MSE A 113 UNP Q9HLN2 MET 113 MODIFIED RESIDUE SEQADV 2ONF GLY B 0 UNP Q9HLN2 EXPRESSION TAG SEQADV 2ONF MSE B 1 UNP Q9HLN2 MET 1 MODIFIED RESIDUE SEQADV 2ONF MSE B 65 UNP Q9HLN2 MET 65 MODIFIED RESIDUE SEQADV 2ONF MSE B 113 UNP Q9HLN2 MET 113 MODIFIED RESIDUE SEQRES 1 A 140 GLY MSE HIS VAL TYR GLU SER ASP VAL SER TRP ILE ASP SEQRES 2 A 140 ASP ARG ARG THR GLU VAL SER VAL GLY ASP HIS ARG ILE SEQRES 3 A 140 GLU VAL ASP SER PRO PRO GLU PHE GLY GLY PRO GLU GLY SEQRES 4 A 140 GLN LEU TYR PRO GLU THR LEU PHE PRO SER VAL LEU ALA SEQRES 5 A 140 SER CYS LEU LEU THR THR PHE LEU GLU PHE LYS ASP ARG SEQRES 6 A 140 MSE GLY ILE ASN LEU LYS SER TRP ASN SER HIS VAL THR SEQRES 7 A 140 ALA GLU LEU GLY PRO SER PRO GLU LYS GLY PHE LYS PHE SEQRES 8 A 140 HIS ARG ILE LYS ILE HIS VAL LYS ILE GLY VAL ASN ASP SEQRES 9 A 140 GLU ASP LYS GLU LYS ILE PRO ARG ALA MSE GLN LEU ALA SEQRES 10 A 140 GLU LYS TYR CYS PHE ILE SER ARG ALA ILE ARG ASN ASN SEQRES 11 A 140 VAL GLU GLU ILE VAL ASP TYR GLU PHE VAL SEQRES 1 B 140 GLY MSE HIS VAL TYR GLU SER ASP VAL SER TRP ILE ASP SEQRES 2 B 140 ASP ARG ARG THR GLU VAL SER VAL GLY ASP HIS ARG ILE SEQRES 3 B 140 GLU VAL ASP SER PRO PRO GLU PHE GLY GLY PRO GLU GLY SEQRES 4 B 140 GLN LEU TYR PRO GLU THR LEU PHE PRO SER VAL LEU ALA SEQRES 5 B 140 SER CYS LEU LEU THR THR PHE LEU GLU PHE LYS ASP ARG SEQRES 6 B 140 MSE GLY ILE ASN LEU LYS SER TRP ASN SER HIS VAL THR SEQRES 7 B 140 ALA GLU LEU GLY PRO SER PRO GLU LYS GLY PHE LYS PHE SEQRES 8 B 140 HIS ARG ILE LYS ILE HIS VAL LYS ILE GLY VAL ASN ASP SEQRES 9 B 140 GLU ASP LYS GLU LYS ILE PRO ARG ALA MSE GLN LEU ALA SEQRES 10 B 140 GLU LYS TYR CYS PHE ILE SER ARG ALA ILE ARG ASN ASN SEQRES 11 B 140 VAL GLU GLU ILE VAL ASP TYR GLU PHE VAL MODRES 2ONF MSE A 1 MET SELENOMETHIONINE MODRES 2ONF MSE A 65 MET SELENOMETHIONINE MODRES 2ONF MSE A 113 MET SELENOMETHIONINE MODRES 2ONF MSE B 1 MET SELENOMETHIONINE MODRES 2ONF MSE B 65 MET SELENOMETHIONINE MODRES 2ONF MSE B 113 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 65 8 HET MSE A 113 13 HET MSE B 1 8 HET MSE B 65 8 HET MSE B 113 13 HET EDO A 140 4 HET EDO A 141 8 HET EDO A 142 4 HET COA B 140 48 HET EDO B 141 4 HETNAM MSE SELENOMETHIONINE HETNAM EDO 1,2-ETHANEDIOL HETNAM COA COENZYME A HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 6(C5 H11 N O2 SE) FORMUL 3 EDO 4(C2 H6 O2) FORMUL 6 COA C21 H36 N7 O16 P3 S FORMUL 8 HOH *306(H2 O) HELIX 1 1 PRO A 30 GLY A 34 5 5 HELIX 2 2 TYR A 41 MSE A 65 1 25 HELIX 3 3 ASP A 103 GLU A 107 5 5 HELIX 4 4 LYS A 108 CYS A 120 1 13 HELIX 5 5 CYS A 120 ARG A 127 1 8 HELIX 6 6 PRO B 30 GLY B 34 5 5 HELIX 7 7 TYR B 41 GLY B 66 1 26 HELIX 8 8 ASP B 103 GLU B 107 5 5 HELIX 9 9 LYS B 108 CYS B 120 1 13 HELIX 10 10 CYS B 120 ARG B 127 1 8 SHEET 1 A 6 HIS A 23 ASP A 28 0 SHEET 2 A 6 ARG A 15 VAL A 20 -1 N VAL A 18 O ILE A 25 SHEET 3 A 6 HIS A 2 TRP A 10 -1 N ASP A 7 O SER A 19 SHEET 4 A 6 LEU B 69 PRO B 82 -1 O VAL B 76 N SER A 6 SHEET 5 A 6 PHE B 88 VAL B 101 -1 O LYS B 98 N ASN B 73 SHEET 6 A 6 GLU B 131 PHE B 138 1 O ILE B 133 N ILE B 95 SHEET 1 B 6 GLU A 131 PHE A 138 0 SHEET 2 B 6 PHE A 88 VAL A 101 1 N VAL A 97 O ASP A 135 SHEET 3 B 6 LEU A 69 PRO A 82 -1 N LYS A 70 O GLY A 100 SHEET 4 B 6 HIS B 2 ASP B 12 -1 O SER B 6 N VAL A 76 SHEET 5 B 6 ARG B 15 VAL B 20 -1 O SER B 19 N ASP B 7 SHEET 6 B 6 HIS B 23 ASP B 28 -1 O ILE B 25 N VAL B 18 LINK C GLY A 0 N MSE A 1 1555 1555 1.35 LINK C MSE A 1 N HIS A 2 1555 1555 1.34 LINK C ARG A 64 N MSE A 65 1555 1555 1.33 LINK C MSE A 65 N GLY A 66 1555 1555 1.32 LINK C ALA A 112 N MSE A 113 1555 1555 1.33 LINK C MSE A 113 N GLN A 114 1555 1555 1.33 LINK C GLY B 0 N MSE B 1 1555 1555 1.34 LINK C MSE B 1 N HIS B 2 1555 1555 1.33 LINK C ARG B 64 N MSE B 65 1555 1555 1.34 LINK C MSE B 65 N GLY B 66 1555 1555 1.32 LINK C ALA B 112 N MSE B 113 1555 1555 1.32 LINK C MSE B 113 N GLN B 114 1555 1555 1.31 CISPEP 1 GLY A 0 MSE A 1 0 4.87 SITE 1 AC1 26 PHE A 33 ARG A 64 LYS A 86 GLY A 87 SITE 2 AC1 26 GLU B 32 THR B 56 PHE B 61 ARG B 64 SITE 3 AC1 26 MSE B 65 ARG B 111 LEU B 115 LYS B 118 SITE 4 AC1 26 TYR B 119 HOH B 147 HOH B 152 HOH B 155 SITE 5 AC1 26 HOH B 171 HOH B 176 HOH B 178 HOH B 189 SITE 6 AC1 26 HOH B 222 HOH B 231 HOH B 258 HOH B 259 SITE 7 AC1 26 HOH B 260 HOH B 263 SITE 1 AC2 4 LYS A 108 ARG A 111 HOH A 143 HOH A 273 SITE 1 AC3 3 LYS A 70 TRP B 10 ILE B 11 SITE 1 AC4 4 TRP A 10 ILE A 11 ASP A 12 LYS B 70 SITE 1 AC5 1 ARG A 64 CRYST1 47.070 68.550 48.670 90.00 98.29 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021250 0.000000 0.003100 0.00000 SCALE2 0.000000 0.014590 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020760 0.00000